Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5138699 | Journal of Proteomics | 2017 | 27 Pages |
Abstract
The main bottleneck in studies aiming to identify novel biomarkers in acute kidney injury (AKI) has been the identification of markers that are predominantly renal. In fact, putative biomarkers for this condition have also been identified in a number of other clinical scenarios, such as cardiovascular diseases, chronic kidney failure or in patients being treated in intensive care units from a number of conditions. Here we propose a comprehensive, sequential screening procedure able to identify and validate potential biomarkers for kidney disease, using kidney ischemia/reperfusion as a paradigm for a kidney pathological event.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Pamella Araujo Malagrino, Gabriela Venturini, PatrÃcia Schneider Yogi, Rafael Dariolli, Kallyandra Padilha, Bianca Kiers, Tamiris Carneiro Gois, Karina Helena Morais Cardozo, Valdemir Melechco Carvalho, Jéssica Silva Salgueiro,